🇩🇪 Germany Country × Condition
acute ischemic stroke Clinical Trials in Germany
Active clinical trials for acute ischemic stroke with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇩🇪 Germany
Active Trials in Germany (4)
NCT03356392
Recruiting
German Stroke Registry - Endovascular Treatment
Enrollment
10,000 pts
Country
🇩🇪 Germany
Universitätsklinikum Hamburg-Eppend...
View Trial → NCT05691244 Phase 3
Recruiting
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Enrollment
514 pts
Country
🇩🇪 Germany
Pharmazz, Inc.
View Trial → NCT06749106
Recruiting
Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage
Enrollment
300 pts
Country
🇩🇪 Germany
Ludwig-Maximilians - University of ...
View Trial → NCT07299994
Recruiting
Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease
Enrollment
462 pts
Country
🇩🇪 Germany
Sigmund Freud PrivatUniversitat
View Trial → Frequently Asked Questions
How many acute ischemic stroke clinical trials are active in Germany?
There are currently 4 active clinical trials for acute ischemic stroke with sites in Germany, of which 4 are actively recruiting patients.
How can I join a acute ischemic stroke clinical trial in Germany?
To join a acute ischemic stroke clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute ischemic stroke trials in Germany?
Active acute ischemic stroke trials in Germany span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology